These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38394643)

  • 21. Serum integrative omics reveals the landscape of human diabetic kidney disease.
    Liu S; Gui Y; Wang MS; Zhang L; Xu T; Pan Y; Zhang K; Yu Y; Xiao L; Qiao Y; Bonin C; Hargis G; Huan T; Yu Y; Tao J; Zhang R; Kreutzer DL; Zhou Y; Tian XJ; Wang Y; Fu H; An X; Liu S; Zhou D
    Mol Metab; 2021 Dec; 54():101367. PubMed ID: 34737094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel ferroptosis gene biomarkers and immune infiltration profiles in diabetic kidney disease via bioinformatics.
    Huang Y; Yuan X
    FASEB J; 2024 Jan; 38(2):e23421. PubMed ID: 38198194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.
    Wei R; Qiao J; Cui D; Pan Q; Guo L
    Front Endocrinol (Lausanne); 2022; 13():883658. PubMed ID: 35721731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unified Mouse and Human Kidney Single-Cell Expression Atlas Reveal Commonalities and Differences in Disease States.
    Zhou J; Abedini A; Balzer MS; Shrestha R; Dhillon P; Liu H; Hu H; Susztak K
    J Am Soc Nephrol; 2023 Nov; 34(11):1843-1862. PubMed ID: 37639336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement Cascade Proteins Correlate with Fibrosis and Inflammation in Early-Stage Type 1 Diabetic Kidney Disease in the Ins2Akita Mouse Model.
    Tserga A; Saulnier-Blache JS; Palamaris K; Pouloudi D; Gakiopoulou H; Zoidakis J; Schanstra JP; Vlahou A; Makridakis M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Key Candidate Genes and Chemical Perturbagens in Diabetic Kidney Disease Using Integrated Bioinformatics Analysis.
    Gao Z; S A; Li XM; Li XL; Sui LN
    Front Endocrinol (Lausanne); 2021; 12():721202. PubMed ID: 34557161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell transcriptomic profiles in the pathophysiology within the microenvironment of early diabetic kidney disease.
    Tsai YC; Kuo MC; Huang JC; Chang WA; Wu LY; Huang YC; Chang CY; Lee SC; Hsu YL
    Cell Death Dis; 2023 Jul; 14(7):442. PubMed ID: 37460555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.
    Jung CY; Yoo TH
    Diabetes Metab J; 2022 Mar; 46(2):181-197. PubMed ID: 35385633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease.
    Wang X; Wu H; Yang G; Xiang J; Xiong L; Zhao L; Liao T; Zhao X; Kang L; Yang S; Liang Z
    Front Endocrinol (Lausanne); 2022; 13():935796. PubMed ID: 35937821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
    Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease.
    Chen S; Li B; Chen L; Jiang H
    BMC Med Genomics; 2023 May; 16(1):90. PubMed ID: 37127580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease.
    Sheng X; Qiu C; Liu H; Gluck C; Hsu JY; He J; Hsu CY; Sha D; Weir MR; Isakova T; Raj D; Rincon-Choles H; Feldman HI; Townsend R; Li H; Susztak K
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29013-29024. PubMed ID: 33144501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.
    Looker HC; Mauer M; Nelson RG
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):192-201. PubMed ID: 29580583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease.
    Xie Y; Jia Y; Cuihua X; Hu F; Xue M; Xue Y
    J Diabetes Res; 2017; 2017():6978984. PubMed ID: 29038788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the Role of CircRNA in Diabetic Kidney Disease from a Novel Perspective: Focusing on Both Glomeruli and Tubuli.
    Liu Y; Zhang L; Wang Y; Bai L; Chen S; Yang J; Wang X
    DNA Cell Biol; 2021 Nov; 40(11):1369-1380. PubMed ID: 34767731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.
    Diao M; Wu Y; Yang J; Liu C; Xu J; Jin H; Wang J; Zhang J; Gao F; Jin C; Tian H; Xu J; Ou Q; Li Y; Xu G; Lu L
    Front Endocrinol (Lausanne); 2022; 13():843721. PubMed ID: 35432190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Zhuang medicine compound Xiancao Granule on diabetic kidney disease: A multi-omics analysis.
    Mo C; Zhao J; Liang J; Chen Y; Wang H; Dai Y; Huang G
    J Ethnopharmacol; 2024 Mar; 321():117517. PubMed ID: 38042391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis.
    Jin H; Kim YA; Lee Y; Kwon SH; Do AR; Seo S; Won S; Seo JH
    BMC Med; 2023 Jan; 21(1):16. PubMed ID: 36627639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
    Chen J; Luo SF; Yuan X; Wang M; Yu HJ; Zhang Z; Yang YY
    J Cell Biochem; 2022 Feb; 123(2):481-492. PubMed ID: 34908186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycolytic lactate in diabetic kidney disease.
    Darshi M; Kugathasan L; Maity S; Sridhar VS; Fernandez R; Limonte CP; Grajeda BI; Saliba A; Zhang G; Drel VR; Kim JJ; Montellano R; Tumova J; Montemayor D; Wang Z; Liu JJ; Wang J; Perkins BA; Lytvyn Y; Natarajan L; Lim SC; Feldman H; Toto R; Sedor JR; Patel J; Waikar SS; Brown J; Osman Y; He J; Chen J; Reeves WB; de Boer IH; Roy S; Vallon V; Hallan S; Gelfond JA; Cherney DZ; Sharma K;
    JCI Insight; 2024 Jun; 9(11):. PubMed ID: 38855868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.